Home » Healthcare » Australia Peritoneal Dialysis Market

Australia Peritoneal Dialysis Market By Type (Continuous Ambulatory Peritoneal Dialysis [CAPD], Automated Peritoneal Dialysis [APD]); By Product (Peritoneal Dialysis Machines, Peritoneal Dialysis Solutions, Dialysis Catheters, Others); By End-User (Hospitals, Dialysis Centers, Home Care Settings) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2019-2022
Base Year	2023
Forecast Period	2024-2032
Australia Peritoneal Dialysis Market Size 2023	USD 69.97 million
Australia Peritoneal Dialysis Market, CAGR	6.18%
Australia Peritoneal Dialysis Market Size 2032	USD 117.08 million

Market Overview

The Australia Peritoneal Dialysis Market is projected to grow from USD 69.97 million in 2023 to USD 117.08 million by 2032, with a compound annual growth rate (CAGR) of 6.18%.

The Australia Peritoneal Dialysis market is driven by the increasing prevalence of chronic kidney diseases (CKD) and the growing demand for home-based dialysis treatment options. As more patients seek alternatives to hemodialysis, peritoneal dialysis offers a convenient and effective solution, contributing to its rising adoption. Additionally, advancements in dialysis technology, including automated peritoneal dialysis systems, are improving treatment efficiency and patient outcomes. The Australian government’s support for chronic disease management and the availability of reimbursement policies further enhance market growth. Moreover, the rising awareness among healthcare providers and patients regarding the benefits of peritoneal dialysis over traditional methods is fueling market expansion. Trends indicate a shift towards personalized treatment plans, where patients receive tailored solutions based on their specific needs, boosting the demand for peritoneal dialysis. These factors combined are expected to propel the market forward at a steady growth rate through the next decade.

The Australia Peritoneal Dialysis market is driven by key players across various regions, with a strong presence in major states like New South Wales, Victoria, and Queensland. These regions are home to some of the leading healthcare providers and dialysis centers that offer advanced treatments and technologies for patients with chronic kidney disease. Key players in the Australian market include Nipro Corporation, Baxter International Inc., Fresenius Medical Care, Terumo Corporation, and Asahi Kasei Medical Co., Ltd. These companies offer a range of products such as peritoneal dialysis machines, dialysis solutions, and catheters, catering to the growing demand for home-based dialysis treatments. With continuous advancements in technology and increased focus on patient-centric care, these companies are poised to expand their presence in the Australian market. Their innovations and commitment to improving dialysis care are essential in addressing the needs of patients across Australia.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market Insights

The Australia Peritoneal Dialysis market is valued at USD 69.97 million in 2023 and is projected to reach USD 117.08 million by 2032, growing at a CAGR of 6.18%.
Increasing prevalence of chronic kidney disease (CKD) is driving the demand for renal replacement therapies like peritoneal dialysis.
Rising preference for home dialysis treatments, particularly peritoneal dialysis, is contributing to market growth.
Technological advancements, including smart dialysis systems and automated machines, are enhancing treatment efficiency and patient comfort.
High costs of treatment and equipment, along with limited access to specialized support, are major market restraints.
Competitive players like Nipro Corporation, Baxter International Inc., and Fresenius Medical Care dominate the market with a strong presence in key Australian regions.
Regional growth is primarily driven by New South Wales, Victoria, and Queensland, where healthcare infrastructure and dialysis services are expanding.

Market Drivers

Rising Prevalence of Chronic Kidney Disease (CKD)

The increasing incidence of chronic kidney disease (CKD) in Australia is one of the primary drivers of the peritoneal dialysis market. For instance, the Australian Institute of Health and Welfare reported that CKD contributed to around 22,000 deaths in 2022, highlighting the severity of the condition. With the aging population and rising rates of conditions such as diabetes and hypertension, which contribute to kidney failure, more individuals are requiring dialysis treatment. As CKD becomes more widespread, the demand for effective renal replacement therapies, including peritoneal dialysis, is expected to grow significantly. This trend is further supported by the growing number of patients opting for home-based dialysis treatments as a more convenient and flexible option.

Government Support and Reimbursement Policies

Government initiatives and favorable reimbursement policies are key factors supporting the growth of the peritoneal dialysis market in Australia. For instance, the Australian government provides financial support for dialysis treatments through programs like the Patient Assistance Transport Scheme (PATS), which helps reduce the financial burden on patients. Additionally, reimbursement for peritoneal dialysis procedures under national health insurance programs encourages both healthcare providers and patients to adopt this method. These supportive policies contribute to the steady increase in market demand for peritoneal dialysis in the country.

Shift Towards Home-Based Dialysis Treatments

Peritoneal dialysis (PD) is gaining popularity due to its home-based treatment capabilities, offering patients greater autonomy compared to hemodialysis. This shift towards home dialysis is driven by the increasing preference among patients for treatments that can be conducted at home, minimizing the need for frequent hospital visits. PD allows patients to manage their condition more independently, making it a highly attractive option for those seeking a more comfortable and convenient treatment plan. This shift is contributing to the steady growth of the peritoneal dialysis market in Australia.

Technological Advancements in Dialysis Equipment

Technological advancements in peritoneal dialysis equipment are playing a crucial role in driving market growth. Innovations such as automated peritoneal dialysis (APD) systems are enhancing treatment efficiency, making it easier for patients to manage their condition at home. These devices automate the dialysis process, reducing the time and effort required from patients. As these systems become more user-friendly and efficient, the adoption of peritoneal dialysis is expected to rise, further expanding the market in Australia.

Market Trends

Integration of Smart Technology in Dialysis Systems

The integration of smart technology in peritoneal dialysis devices is revolutionizing the market. For instance, the CSIRO developed a mobile health platform, PD-BUDDy, which includes a smartphone app for patients and an online portal for clinicians to monitor progress in real time. With innovations like cloud-based monitoring, remote patient tracking, and real-time data sharing, healthcare providers can better monitor patients’ progress and adjust treatment as needed. Smart dialysis systems also improve patient convenience by reducing the number of hospital visits and providing more control over treatment. These technological advancements not only enhance patient outcomes but also optimize the overall efficiency of dialysis processes, contributing to the growing demand for peritoneal dialysis in Australia.

Increasing Preference for Personalized Treatment Plans

A growing trend in the Australia Peritoneal Dialysis market is the shift towards personalized treatment plans. As patients seek more tailored solutions to meet their unique healthcare needs, providers are offering individualized treatment regimens based on factors such as lifestyle, comorbidities, and personal preferences. Personalized peritoneal dialysis options, including automated systems and adjustable treatment schedules, are becoming more common. This trend reflects the broader healthcare industry’s focus on patient-centric care, enhancing the overall experience and encouraging greater adoption of peritoneal dialysis.

Growing Awareness of Home Dialysis Benefits

There is a noticeable trend of increasing awareness regarding the benefits of home dialysis, particularly peritoneal dialysis, among both patients and healthcare professionals in Australia. Public health campaigns, patient education, and outreach programs are helping to inform individuals about the advantages of home-based treatment options. These include the flexibility to manage treatment at home, improved quality of life, and fewer hospital visits. As patients become more knowledgeable about these benefits, the adoption of peritoneal dialysis is expected to rise, driving market growth.

Advancements in Training and Support Services

A significant trend in the Australia Peritoneal Dialysis market is the development of enhanced training and support services for patients undergoing peritoneal dialysis. Healthcare providers are offering more comprehensive training programs that teach patients how to effectively perform dialysis at home, handle complications, and maintain equipment. These programs, often accompanied by ongoing support from healthcare teams, increase patient confidence and improve treatment adherence. As a result, more patients are choosing peritoneal dialysis, which is further fueling the market’s expansion.

Market Challenges Analysis

High Costs of Peritoneal Dialysis Treatment

One of the significant challenges facing the Australia Peritoneal Dialysis market is the high cost associated with both treatment and equipment. For instance, the Australian Government’s Medical Costs Finder highlights that patients in rural areas often face difficulties accessing specialized training for peritoneal dialysis, which is crucial for effective home treatment. Although peritoneal dialysis offers numerous benefits, including the convenience of home treatment, the upfront costs for setting up the necessary equipment and ongoing maintenance can be a barrier for many patients. The cost of consumables, such as dialysate solutions and catheters, further adds to the financial burden. Despite government reimbursement programs, patients may still find it difficult to afford these treatments, particularly those without sufficient insurance coverage or financial resources. These high costs pose a challenge to the widespread adoption of peritoneal dialysis, limiting its potential to fully address the growing demand for renal replacement therapies in Australia.

Limited Access to Specialized Training and Support

Another challenge in the Australian Peritoneal Dialysis market is the limited access to specialized training and support services in some regions. Although the availability of home dialysis treatment is growing, patients in rural or remote areas may struggle to access proper training on how to perform peritoneal dialysis independently. Specialized support services, including home visits from healthcare providers, may be scarce in these areas, hindering patient confidence and treatment success. Without adequate education and ongoing assistance, patients may be more likely to experience complications or fail to adhere to their treatment plan, which could ultimately affect the overall success of peritoneal dialysis as a viable long-term solution. This limitation in accessibility presents a challenge to the broader adoption and effectiveness of peritoneal dialysis across the country.

Market Opportunities

Expansion of Home Dialysis Programs

One of the key opportunities for the Australia Peritoneal Dialysis market lies in the expansion of home dialysis programs. With the growing preference for at-home treatment options, there is a significant opportunity to increase the adoption of peritoneal dialysis as a home-based therapy. As patients seek greater flexibility, convenience, and control over their treatment, healthcare providers can tap into this demand by enhancing home dialysis support services. Expanding access to home dialysis education, training, and remote monitoring will not only improve patient outcomes but also reduce the burden on hospital infrastructure, making peritoneal dialysis a more viable option for a larger segment of the population. This shift could lead to a higher uptake of peritoneal dialysis, benefiting both patients and the overall healthcare system.

Technological Advancements and Innovation

Technological advancements in peritoneal dialysis equipment present another substantial market opportunity. The development of more efficient, user-friendly, and automated systems has the potential to make peritoneal dialysis even more attractive to patients and healthcare providers. Innovations such as smart dialysis machines, which offer remote monitoring and real-time data sharing, can further enhance treatment outcomes by enabling more personalized care. Additionally, advancements in dialysis consumables and automated peritoneal dialysis (APD) devices can reduce treatment time and improve patient comfort. These technological innovations present opportunities for companies to introduce new products and services that cater to the evolving needs of patients, thereby driving market growth in Australia. As the technology becomes more accessible and affordable, it is expected to boost the adoption of peritoneal dialysis across the country.

Market Segmentation Analysis:

By Type:

The Australia Peritoneal Dialysis market is segmented by type into Continuous Ambulatory Peritoneal Dialysis (CAPD) and Automated Peritoneal Dialysis (APD). CAPD holds a significant share of the market due to its simplicity and the ability for patients to manage their dialysis treatments independently at home without the need for machines. This type is particularly favored by patients who prefer a hands-on approach to their treatment. However, the market for APD is growing rapidly, driven by advancements in technology that make the process more efficient and comfortable. APD systems automate the peritoneal dialysis process, allowing for multiple cycles during the night while the patient sleeps, reducing the time required for treatment. The demand for APD is increasing as patients seek more convenient and less time-consuming alternatives to traditional methods, thus driving the overall growth in the segment.

By Product:

The Australia Peritoneal Dialysis market is also segmented by product, which includes peritoneal dialysis machines, dialysis solutions, dialysis catheters, and other related accessories. Peritoneal dialysis machines and solutions dominate the market, as these products are essential for the dialysis process. The increasing adoption of automated systems and the rising demand for home dialysis treatments have boosted the need for advanced peritoneal dialysis machines and automated systems. Dialysis catheters are another crucial product segment, as they are necessary for establishing access to the peritoneum. The “others” segment includes consumables such as transfer sets and sterile bags, which support the dialysis procedure. These products are vital to maintaining the overall efficiency and effectiveness of peritoneal dialysis treatments. As the market evolves, product innovations are expected to enhance treatment outcomes and improve patient compliance, driving further growth across these segments.

Segments:

Based on Type:

Continuous Ambulatory Peritoneal Dialysis (CAPD)
Automated Peritoneal Dialysis (APD)

Based on Product:

Peritoneal Dialysis Machines
Peritoneal Dialysis Solutions
Dialysis Catheters
Others

Based on End-user:

Hospitals
Dialysis Centers
Home Care Settings

Based on the Geography:

New South Wales
Victoria
Queensland
Western Australia (WA)
South Australia

Regional Analysis

New South Wales and Victoria

New South Wales (NSW) and Victoria together hold the largest share of the Australia Peritoneal Dialysis market, accounting for approximately 55% of the total market. These two states benefit from well-established healthcare infrastructure and high population densities, which contribute to increased demand for renal replacement therapies, including peritoneal dialysis. NSW, with its capital Sydney, is a major hub for healthcare services and offers advanced medical facilities, making it a key region for the adoption of peritoneal dialysis. Similarly, Victoria, which includes Melbourne, has a strong healthcare system and a high prevalence of chronic kidney diseases, fueling the demand for dialysis treatments. The robust healthcare policies, availability of specialized dialysis centers, and high awareness of kidney disease management in these regions

Queensland

Queensland holds a market share of approximately 20% in the Australian Peritoneal Dialysis market. The region’s growing aging population and the increasing prevalence of chronic kidney disease (CKD) contribute to the demand for dialysis treatments. Queensland’s healthcare system continues to expand, with improved access to dialysis services in both urban and regional areas. Brisbane, the state capital, is a focal point for advanced medical research and dialysis technology. Furthermore, Queensland’s large rural and remote population has led to the rising adoption of home-based dialysis options, such as peritoneal dialysis, which are more convenient for patients living far from urban centers. With government initiatives to support home dialysis and reduce healthcare costs, the market is expected to experience steady growth in Queensland in the coming years.

Western Australia (WA)

Western Australia (WA) has a market share of approximately 10% in the Australian Peritoneal Dialysis market. The region faces unique challenges, such as its vast geographic area and remote population centers, which can limit access to specialized medical care. However, the demand for peritoneal dialysis is on the rise due to a combination of increasing CKD cases and greater patient preference for home dialysis. Perth, the capital city, remains the central hub for healthcare, offering a wide range of dialysis services and technology. As Western Australia continues to focus on improving healthcare access for its rural and remote communities, peritoneal dialysis is likely to become an increasingly popular option for patients who require convenient and flexible treatment solutions. Additionally, government and healthcare system improvements in WA are expected to support market growth.

South Australia

South Australia (SA) holds a smaller market share of around 15% in the peritoneal dialysis market. Despite being a relatively smaller market compared to the eastern states, SA has seen steady growth in the adoption of peritoneal dialysis. Adelaide, the capital city, is home to several specialized medical centers offering peritoneal dialysis options to patients with CKD. The state has been proactive in promoting home-based dialysis, and increasing awareness among healthcare providers and patients is driving the demand for this treatment option. The healthcare infrastructure in SA is improving, particularly in terms of dialysis facilities and patient education programs. As the state continues to address the needs of its aging population and enhance access to dialysis treatments, South Australia is expected to experience moderate growth in the market over the next decade.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Player Analysis

Nipro Corporation
Baxter International Inc.
Fresenius Medical Care
Terumo Corporation
Asahi Kasei Medical Co., Ltd.
Huaren Pharmaceutical Co., Ltd.
JMS Co., Ltd.
Kawasumi Laboratories Inc.
Medtronic plc
Pacific Hospital Supply Co., Ltd.

Competitive Analysis

The Australia Peritoneal Dialysis market is highly competitive, with leading players offering advanced products and services to cater to the growing demand for renal replacement therapies. Key players such as Nipro Corporation, Baxter International Inc., Fresenius Medical Care, Terumo Corporation, Asahi Kasei Medical Co., Ltd., Huaren Pharmaceutical Co., Ltd., JMS Co., Ltd., Kawasumi Laboratories Inc., Medtronic plc, and Pacific Hospital Supply Co., Ltd. are at the forefront of driving market innovation. For instance, during the 2021 survey period, 1,175 people in Australia commenced maintenance peritoneal dialysis (PD), highlighting the significant uptake of these treatments. Leading companies in the market focus on improving the efficiency and accessibility of peritoneal dialysis treatments by offering a range of products such as dialysis machines, solutions, and catheters. These players continuously invest in research and development to introduce more user-friendly, automated systems that provide convenience for patients undergoing home dialysis. The market is also driven by the increasing demand for home-based dialysis solutions, as patients seek greater flexibility and control over their treatment. As a result, companies that offer automated peritoneal dialysis (APD) systems with remote monitoring features are gaining a competitive advantage. Additionally, advancements in dialysis consumables, such as high-quality catheters and sterile solutions, have become key differentiators. Companies are also expanding their reach through strategic partnerships and improving distribution networks across regions like New South Wales, Victoria, and Queensland. While market challenges such as the high cost of treatment and limited specialized training persist, the continuous push for technological innovation and expanding access to home dialysis services is helping companies maintain competitiveness in the Australian market.

Recent Developments

In August 2024, Baxter International Inc (US) and Carlyle (US) signed a definitive agreement under which Carlyle will acquire Baxter’s Kidney Care segment. The segment will be named Vantive, with the aim of creating a standalone kidney care company.

In April 2023, Medtronic plc (Ireland) and DaVita Inc (US) launched Mozarc Medical—an independent new company that aims to reshape kidney health and drive patient-centered technology solutions.

In August 2022, Fresenius Medical Care AG (Germany) acquired InterWell Health (US), a physician organization that drives innovation in the kidney care space in the US, and Cricket Health. Inc (US), provider of value-based kidney care with patient engagement and data platform.

Market Concentration & Characteristics

The Australia Peritoneal Dialysis market exhibits a moderate level of concentration, with a few dominant players controlling a significant share of the market. This concentration is driven by the presence of large, multinational companies that offer a comprehensive range of products and services, such as peritoneal dialysis machines, solutions, and consumables. These players often have extensive distribution networks, strong brand recognition, and the capacity for ongoing research and development, which gives them a competitive edge. However, the market also includes regional and smaller companies that provide specialized products, allowing for some diversity within the sector. The market is characterized by a focus on technological innovation, particularly in home-based dialysis solutions. As more patients prefer home dialysis for its convenience, companies are increasingly developing automated peritoneal dialysis (APD) systems and advanced monitoring devices to improve patient outcomes and enhance the ease of treatment. Additionally, there is a growing emphasis on providing high-quality dialysis consumables, such as catheters and sterile solutions, which are crucial for the overall success of peritoneal dialysis therapy. Despite challenges like the high cost of treatment, the market continues to grow, driven by increasing demand for renal replacement therapies and the ongoing shift toward home dialysis solutions in Australia.

Report Coverage

The research report offers an in-depth analysis based on Type, Product, End-User and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The Australia Peritoneal Dialysis market is expected to continue growing due to the increasing prevalence of chronic kidney disease (CKD).
Technological advancements in automated peritoneal dialysis (APD) systems will drive market growth and improve patient convenience.
A shift toward home dialysis solutions is anticipated to gain momentum as more patients seek flexible and patient-centric treatment options.
Increased investment in research and development by key players will lead to more efficient and user-friendly dialysis equipment.
Expanding access to dialysis services in rural and remote regions will contribute to the broader adoption of peritoneal dialysis.
The rising demand for cost-effective treatment solutions will promote the growth of innovative dialysis consumables and accessories.
Government policies and healthcare reforms are expected to support the accessibility and affordability of peritoneal dialysis in Australia.
Strategic partnerships between healthcare providers and dialysis technology companies will enhance product offerings and regional presence.
The market will see a rise in patient education programs to improve compliance and treatment outcomes.
The increasing focus on home-based healthcare models will further expand the use of peritoneal dialysis as a primary renal replacement therapy.

CHAPTER NO. 1 : INTRODUCTION 20

1.1.1. Report Description 20

Purpose of the Report 20

USP & Key Offerings 20

1.1.2. Key Benefits for Stakeholders 20

1.1.3. Target Audience 21

1.1.4. Report Scope 21

CHAPTER NO. 2 : EXECUTIVE SUMMARY 22

2.1. Peritoneal Dialysis Market Snapshot 22

2.1.1. Australia Peritoneal Dialysis Market, 2018 – 2032 (USD Million) 23

CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 24

3.1. Russia-Ukraine and Israel-Palestine War Impacts 24

CHAPTER NO. 4 : PERITONEAL DIALYSIS MARKET – INDUSTRY ANALYSIS 25

4.1. Introduction 25

4.2. Market Drivers 26

4.2.1. Rising prevalence of chronic kidney diseases (CKD) 26

4.2.2. Growing adoption of home dialysis treatments 27

4.3. Market Restraints 28

4.3.1. High cost of peritoneal dialysis equipment and treatments 28

4.4. Market Opportunities 29

4.4.1. Technological advancements in automated dialysis systems 29

4.5. Porter’s Five Forces Analysis 30

4.6. Buying Criteria 31

CHAPTER NO. 5 : IMPORT EXPORT ANALYSIS 32

5.1. Import Analysis by Australia 32

5.1.1. Australia Peritoneal Dialysis Market Import Volume/Revenue, By Australia, 2018 – 2023 32

5.2. Export Analysis by Australia 33

5.2.1. Australia Peritoneal Dialysis Market Export Volume/Revenue, By Australia, 2018 – 2023 33

CHAPTER NO. 6 : DEMAND SUPPLY ANALYSIS 34

6.1. Demand Analysis by Australia 34

6.1.1. Australia Peritoneal Dialysis Market Demand Volume/Revenue, By Australia, 2018 – 2023 34

6.2. Supply Analysis by Australia 35

6.2.1. Australia Peritoneal Dialysis Market Supply Volume/Revenue, By Australia, 2018 – 2023 35

CHAPTER NO. 7 : PRODUCTION ANALYSIS 36

7.1. Production Analysis by Australia 36

7.1.1. Australia Peritoneal Dialysis Market Production Volume/Revenue, By Australia, 2018 – 2023 36

CHAPTER NO. 8 : PRICE ANALYSIS 37

8.1. Price Analysis by Type 37

8.1.1. Australia Peritoneal Dialysis Market Price, By Type, 2018 – 2023 37

8.1.2. Australia Type Market Price, By Type, 2018 – 2023 37

CHAPTER NO. 9 : RAW MATERIALS ANALYSIS 38

9.1. Key Raw Materials and Suppliers 38

9.2. Key Raw Materials Price Trend 38

CHAPTER NO. 10 : MANUFACTURING COST ANALYSIS 39

10.1. Manufacturing Cost Analysis 39

10.2. Manufacturing Process 39

CHAPTER NO. 11 : ANALYSIS COMPETITIVE LANDSCAPE 40

11.1. Company Market Share Analysis – 2023 40

11.2. Value Chain Analysis 40

11.2.1. Australia Peritoneal Dialysis Market: Company Market Share, by Volume, 2023 41

11.2.2. Australia Peritoneal Dialysis Market: Company Market Share, by Revenue, 2023 42

11.2.3. Australia Peritoneal Dialysis Market: Top 6 Company Market Share, by Revenue, 2023 42

11.2.4. Australia Peritoneal Dialysis Market: Top 3 Company Market Share, by Revenue, 2023 43

11.3. Australia Peritoneal Dialysis Market Company Volume Market Share, 2023 44

11.4. Australia Peritoneal Dialysis Market Company Revenue Market Share, 2023 45

11.5. Company Assessment Metrics, 2023 45

11.5.1. Stars 45

11.5.2. Emerging Leaders 45

11.5.3. Pervasive Players 45

11.5.4. Participants 45

11.6. Start-ups /SMEs Assessment Metrics, 2023 45

11.6.1. Progressive Companies 45

11.6.2. Responsive Companies 46

11.6.3. Dynamic Companies 46

11.6.4. Starting Blocks 46

11.7. Strategic Developments 47

11.7.1. Acquisitions & Mergers 47

New Product Launch 47

Australia Expansion 47

11.8. Key Players Product Matrix 48

CHAPTER NO. 12 : PESTEL & ADJACENT MARKET ANALYSIS 49

12.1. PESTEL 49

12.1.1. Political Factors 49

12.1.2. Economic Factors 49

12.1.3. Social Factors 49

12.1.4. Technological Factors 49

12.1.5. Environmental Factors 49

12.1.6. Legal Factors 49

12.2. Adjacent Market Analysis 49

CHAPTER NO. 13 : PERITONEAL DIALYSIS MARKET – BY TYPE SEGMENT ANALYSIS 50

13.1. Peritoneal Dialysis Market Overview, by Type Segment 50

13.1.1. Peritoneal Dialysis Market Revenue Share, By Type, 2023 & 2032 51

13.1.2. Peritoneal Dialysis Market Attractiveness Analysis, By Type 52

13.1.3. Incremental Revenue Growth Opportunity, by Type, 2024 – 2032 52

13.1.4. Peritoneal Dialysis Market Revenue, By Type, 2018, 2023, 2027 & 2032 53

13.2. Continuous Ambulatory Peritoneal Dialysis (CAPD) 54

13.3. Automated Peritoneal Dialysis (APD) 55

CHAPTER NO. 14 : PERITONEAL DIALYSIS MARKET – BY PRODUCT SEGMENT ANALYSIS 56

14.1. Peritoneal Dialysis Market Overview, by Product Segment 56

14.1.1. Peritoneal Dialysis Market Revenue Share, By Product, 2023 & 2032 57

14.1.2. Peritoneal Dialysis Market Attractiveness Analysis, By Product 58

14.1.3. Incremental Revenue Growth Opportunity, by Product, 2024 – 2032 58

14.1.4. Peritoneal Dialysis Market Revenue, By Product, 2018, 2023, 2027 & 2032 59

14.2. Peritoneal Dialysis Machines 60

14.3. Peritoneal Dialysis Solutions 61

14.4. Dialysis Catheters 62

14.5. Others 63

CHAPTER NO. 15 : PERITONEAL DIALYSIS MARKET – BY END-USER SEGMENT ANALYSIS 64

15.1. Peritoneal Dialysis Market Overview, by End-user Segment 64

15.1.1. Peritoneal Dialysis Market Revenue Share, By End-user, 2023 & 2032 65

15.1.2. Peritoneal Dialysis Market Attractiveness Analysis, By End-user 66

15.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 66

15.1.4. Peritoneal Dialysis Market Revenue, By End-user, 2018, 2023, 2027 & 2032 67

15.2. Hospitals 68

15.3. Dialysis Centers 69

15.4. Home Care Settings 70

CHAPTER NO. 16 : PERITONEAL DIALYSIS MARKET – AUSTRALIA ANALYSIS 71

16.1. Type 71

16.1.1. Australia Peritoneal Dialysis Market Revenue, By Type, 2018 – 2023 (USD Million) 71

16.2. Australia Peritoneal Dialysis Market Revenue, By Type, 2024 – 2032 (USD Million) 71

16.3. Product 72

16.3.1. Australia Peritoneal Dialysis Market Revenue, By Product, 2018 – 2023 (USD Million) 72

16.3.2. Australia Peritoneal Dialysis Market Revenue, By Product, 2024 – 2032 (USD Million) 72

16.4. End-user 73

16.4.1. Australia Peritoneal Dialysis Market Revenue, By End-user, 2018 – 2023 (USD Million) 73

16.4.2. Australia Peritoneal Dialysis Market Revenue, By End-user, 2024 – 2032 (USD Million) 73

CHAPTER NO. 17 : COMPANY PROFILES 74

17.1. Nipro Corporation 74

17.1.1. Company Overview 74

17.1.2. Product Portfolio 74

17.1.3. Swot Analysis 74

17.1.4. Business Strategy 75

17.1.5. Financial Overview 75

17.2. Baxter International Inc. 76

17.3. Fresenius Medical Care 76

17.4. Terumo Corporation 76

17.5. Asahi Kasei Medical Co., Ltd. 76

17.6. Huaren Pharmaceutical Co., Ltd. 76

17.7. JMS Co., Ltd. 76

17.8. Kawasumi Laboratories Inc. 76

17.9. Medtronic plc 76

17.10. Pacific Hospital Supply Co., Ltd. 76

List of Figures

FIG NO. 1. Australia Peritoneal Dialysis Market Revenue, 2018 – 2032 (USD Million) 22

FIG NO. 2. Porter’s Five Forces Analysis for Australia Peritoneal Dialysis Market 29

FIG NO. 3. Australia Peritoneal Dialysis Market Import Volume/Revenue, By Australia, 2018 – 2023 31

FIG NO. 4. Australia Peritoneal Dialysis Market Export Volume/Revenue, By Australia, 2018 – 2023 32

FIG NO. 5. Australia Peritoneal Dialysis Market Demand Volume/Revenue, By Australia, 2018 – 2023 33

FIG NO. 6. Australia Peritoneal Dialysis Market Supply Volume/Revenue, By Australia, 2018 – 2023 34

FIG NO. 7. Australia Peritoneal Dialysis Market Production Volume/Revenue, By Australia, 2018 – 2023 35

FIG NO. 8. Australia Peritoneal Dialysis Market Price, By Type, 2018 – 2023 36

FIG NO. 9. Raw Materials Price Trend Analysis, 2018 – 2023 37

FIG NO. 10. Manufacturing Cost Analysis 38

FIG NO. 11. Manufacturing Process 38

FIG NO. 12. Value Chain Analysis for Australia Peritoneal Dialysis Market 39

FIG NO. 13. Company Share Analysis, 2023 40

FIG NO. 14. Company Share Analysis, 2023 41

FIG NO. 15. Company Share Analysis, 2023 41

FIG NO. 16. Company Share Analysis, 2023 42

FIG NO. 17. Peritoneal Dialysis Market – Company Volume Market Share, 2023 43

FIG NO. 18. Peritoneal Dialysis Market – Company Revenue Market Share, 2023 44

FIG NO. 19. Peritoneal Dialysis Market Revenue Share, By Type, 2023 & 2032 50

FIG NO. 20. Market Attractiveness Analysis, By Type 51

FIG NO. 21. Incremental Revenue Growth Opportunity by Type, 2024 – 2032 51

FIG NO. 22. Peritoneal Dialysis Market Revenue, By Type, 2018, 2023, 2027 & 2032 52

FIG NO. 23. Australia Peritoneal Dialysis Market for Continuous Ambulatory Peritoneal Dialysis (CAPD), Revenue (USD Million) 2018 – 2032 53

FIG NO. 24. Australia Peritoneal Dialysis Market for Automated Peritoneal Dialysis (APD), Revenue (USD Million) 2018 – 2032 54

FIG NO. 25. Peritoneal Dialysis Market Revenue Share, By Product, 2023 & 2032 56

FIG NO. 26. Market Attractiveness Analysis, By Product 57

FIG NO. 27. Incremental Revenue Growth Opportunity by Product, 2024 – 2032 57

FIG NO. 28. Peritoneal Dialysis Market Revenue, By Product, 2018, 2023, 2027 & 2032 58

FIG NO. 29. Australia Peritoneal Dialysis Market for Peritoneal Dialysis Machines, Revenue (USD Million) 2018 – 2032 59

FIG NO. 30. Australia Peritoneal Dialysis Market for Peritoneal Dialysis Solutions, Revenue (USD Million) 2018 – 2032 60

FIG NO. 31. Australia Peritoneal Dialysis Market for Dialysis Catheters, Revenue (USD Million) 2018 – 2032 61

FIG NO. 32. Australia Peritoneal Dialysis Market for Others, Revenue (USD Million) 2018 – 2032 62

FIG NO. 33. Peritoneal Dialysis Market Revenue Share, By End-user, 2023 & 2032 64

FIG NO. 34. Market Attractiveness Analysis, By End-user 65

FIG NO. 35. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032 65

FIG NO. 36. Peritoneal Dialysis Market Revenue, By End-user, 2018, 2023, 2027 & 2032 66

FIG NO. 37. Australia Peritoneal Dialysis Market for Hospitals, Revenue (USD Million) 2018 – 2032 67

FIG NO. 38. Australia Peritoneal Dialysis Market for Dialysis Centers, Revenue (USD Million) 2018 – 2032 68

FIG NO. 39. Australia Peritoneal Dialysis Market for Home Care Settings, Revenue (USD Million) 2018 – 2032 69

List of Tables

TABLE NO. 1. : Australia Peritoneal Dialysis Market: Snapshot 21

TABLE NO. 2. : Drivers for the Peritoneal Dialysis Market: Impact Analysis 25

TABLE NO. 3. : Restraints for the Peritoneal Dialysis Market: Impact Analysis 27

TABLE NO. 4. : Australia Peritoneal Dialysis Market Revenue, By Type, 2018 – 2023 36

TABLE NO. 5. : Key Raw Materials & Suppliers 37

TABLE NO. 6. : Australia Peritoneal Dialysis Market Revenue, By Type, 2018 – 2023 (USD Million) 70

TABLE NO. 7. : Australia Peritoneal Dialysis Market Revenue, By Type, 2024 – 2032 (USD Million) 70

TABLE NO. 8. : Australia Peritoneal Dialysis Market Revenue, By Product, 2018 – 2023 (USD Million) 71

TABLE NO. 9. : Australia Peritoneal Dialysis Market Revenue, By Product, 2024 – 2032 (USD Million) 71

TABLE NO. 10. : Australia Peritoneal Dialysis Market Revenue, By End-user, 2018 – 2023 (USD Million) 72

TABLE NO. 11. : Australia Peritoneal Dialysis Market Revenue, By End-user, 2024 – 2032 (USD Million) 72

Frequently Asked Questions

What is the current size of the Australia Peritoneal Dialysis market?

The Australia Peritoneal Dialysis market is currently valued at USD 69.97 million in 2023 and is projected to grow to USD 117.08 million by 2032, reflecting a compound annual growth rate (CAGR) of 6.18%.

What factors are driving the growth of the Australia Peritoneal Dialysis market?

The market’s growth is primarily driven by the increasing prevalence of chronic kidney disease (CKD), the rising preference for home-based dialysis treatments, and advancements in dialysis technology such as automated peritoneal dialysis (APD) systems. Additionally, government support through reimbursement policies and heightened awareness of the benefits of peritoneal dialysis contribute significantly to market expansion.

What are the key segments within the Australia Peritoneal Dialysis market?

The market is segmented by type into Continuous Ambulatory Peritoneal Dialysis (CAPD) and Automated Peritoneal Dialysis (APD). It is also segmented by product, including peritoneal dialysis machines, dialysis solutions, dialysis catheters, and other accessories. End-user segments include hospitals, dialysis centers, and home care settings, while geographical segments focus on key regions such as New South Wales, Victoria, and Queensland.

What are some challenges faced by the Australia Peritoneal Dialysis market?

High costs associated with treatment and equipment, as well as limited access to specialized training and support services, particularly in rural and remote areas, pose significant challenges. These factors can hinder the adoption of peritoneal dialysis, despite its benefits for home-based care.

Purchase Options

Single User

$2699

Multi User

$3699

Custom Report

$5699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –